Kevin Pong

Kevin Pong currently serves as the Senior Vice President of Corporate Development at Akebia Therapeutics, a position held since September 2024. Prior to this role, Kevin Pong was the Chief Business Officer at NeuroTrauma Sciences, LLC from January 2023 to December 2023 and held the same title at Anima Biotech from January 2018 to December 2023. Additionally, Kevin Pong was the Vice President of Business Development & Licensing at Summit Therapeutics plc from January 2017 to December 2018 and served as Senior Director of Business Development at Fortress Biotech, Inc. from January 2016 to December 2017. Kevin Pong holds a Bachelor of Science in Biological Sciences from the University of Southern California and an MBA in Business Administration from Rutgers University.